Meningitis vaccine trial for infants 3-5 months old
Treatments studied
Part of Brain & nervous system, Infections clinical trials.
This trial tests a vaccine that protects against four types of meningococcal bacteria (groups A, C, W, and Y) in healthy babies aged 3 to 5 months. The vaccine is given to help prevent meningitis and other serious infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be between 3 and 5 months old and generally healthy.
- You must be able to bring your baby to all study visits and follow the study plan.
- Your baby must not have had any meningococcal vaccine before.
- Your baby must not have serious medical conditions, like immune system problems, bleeding disorders, or significant allergies to vaccine ingredients.
- Your baby must not have been born before 37 weeks or after 42 weeks, and birth weight must be between 2500g (5.5 lbs) and 4000g (8.8 lbs).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new vaccine safely protects infants aged 6 to 11 months against four types of meningococcal bacteria that can cause serious infections like meningitis and blood infections. It is designed for healthy babies who have not yet received any meningococcal vaccine.
This study tests a vaccine that protects against four common types of meningitis (groups A, C, Y, and W135) in toddlers aged 12–23 months. It helps researchers see if the vaccine is safe and works well for young children.
This trial tests a new combination vaccine that protects against whooping cough, Haemophilus influenzae type b (a cause of meningitis and pneumonia), and several types of meningococcal disease (a cause of meningitis and bloodstream infections). It may help reduce the number of shots needed for children.
This study tests a booster shot of a meningococcal vaccine (which protects against four types of meningitis) in children who already received the same type of vaccine years ago. The goal is to see if a booster can refresh and strengthen protection against these serious infections.
This study enrolls children and newborns with suspected or confirmed bacterial meningitis. The goal is to understand and improve care for serious infections that affect the lining around the brain.
This study tests an experimental vaccine to protect babies and toddlers from meningitis (a serious infection of the brain and spinal cord). It checks how well the vaccine works and how safe it is in young children.
Hear when a new Epidemic Meningitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.